<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Hepatic Disorders in Children</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

  <h1>Hepatic Disorders in Children</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
          <br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Liver Diseases</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Liver problems in children</strong> are often related to either infection or inflammation, causing what is known as <strong>hepatitis</strong>.</li>
                <li>The causes of liver disease in children can be <strong>congenital</strong> or <strong>acquired</strong>.</li>
                <li>Common acquired causes include <strong>infections</strong>, often caused by viruses, drugs, as well as other toxins.</li>
                <li>Clinically, children presenting with liver disease might be <strong>asymptomatic</strong> or may present with <strong>non-specific symptoms</strong> and/or with <strong>liver-specific symptoms</strong>.</li>
            </ul>
            
            <section id='heading-1-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-1-1'>General Symptoms</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Most children with liver problems will have <strong>mild symptoms</strong> early in the disease, while some may not show any symptoms at all.</li>
                        <li><strong>General symptoms of liver disease</strong> in children can be mistaken for other mild conditions, such as the flu.</li>
                        <li>These general symptoms include:
                            <ul>
                                <li><strong>Nausea</strong> and <strong>vomiting</strong></li>
                                <li>Generalized <strong>tiredness</strong> or <strong>malaise</strong></li>
                                <li>Loss of appetite with <strong>dehydration</strong> or <strong>headache</strong></li>
                            </ul>
                        </li>
                    </ul>
                    
    
                </div>
              </section>

              <section id='heading-1-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-1-2'>Hepatic Symptoms</a>
                  </h3>
                </header>
                <div class='body'>

                    <h4>Hepatomegaly</h4>
                    <ul>
                        <li>The most common specific symptom of liver problems in children is <strong>hepatomegaly</strong>.</li>
                        <li><strong>Enlargement of the liver</strong> can be due to several mechanisms.</li>
                        <li>It is a mass descending below the right costal margin and costal angle, moves early with respiration, and cannot be palpated above. It has <strong>two lobes</strong> with a notch between them, and the upper border is at the <strong>5th intercostal space (ICS) in the midclavicular line (MCL)</strong>.</li>
                        <li>In children, the normal liver edge can be felt up to <strong>2 cm below the right costal margin</strong>. In a newborn infant, extension of the liver edge >3.5 cm below the costal margin in the right midclavicular line suggests hepatic enlargement.</li>
                    </ul>
                    
                    <h4>Jaundice</h4>
                    <ul>
                        <li><strong>Jaundice</strong> may be the earliest and only sign of hepatic dysfunction.</li>
                        <li>Caused by the deposition of bilirubin in the skin, it is a common manifestation of liver problems.</li>
                        <li><strong>Bilirubin</strong> is a byproduct of normal cell metabolism and is usually eliminated by the liver. When the liver is damaged, it cannot eliminate bilirubin appropriately, leading to its deposition under the skin and in the conjunctiva (the white part of the eyes).</li>
                        <li><strong>Yellow discoloration</strong> of the sclera, skin, and mucous membranes is a sign that hyperbilirubinemia exists.</li>
                        <li>Clinically apparent jaundice in children and adults occurs when the serum concentration of bilirubin reaches <strong>2-3 mg/dL</strong> (34-51 Œºmol/L); however, a neonate may not appear icteric until the bilirubin level is over <strong>5 mg/dL</strong> (85 Œºmol/L).</li>
                        <li>Hyperbilirubinemia can be <strong>conjugated</strong> or <strong>unconjugated</strong>.</li>
                        <li>An unconjugated hyperbilirubinemia may indicate increased production, hemolysis, reduced hepatic removal, or altered metabolism of bilirubin.</li>
                        <li>A conjugated bilirubinemia (>20% of total) reflects decreased excretion by damaged hepatic parenchymal cells or disease of the biliary tract, which may be due to sepsis, endocrine or metabolic disease, inflammation of the liver, or obstruction.</li>
                    </ul>
                    
    
                </div>
              </section>

              <section id='heading-1-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-1-3'>Other symptoms</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4>Pruritus (Itching)</h4>
                    <p><strong>Intense itching</strong>, often generalized, but sometimes localized to the hands and feet. Pruritus in liver disease is primarily due to the accumulation of bile salts in the skin, which occurs when bile excretion is impaired.</p>
                    
                    <h4>Spider Angiomas</h4>
                    <p><strong>Small, spider-like blood vessels</strong> visible on the skin, typically on the face, neck, upper chest, and arms. These are a result of increased estrogen levels due to impaired liver metabolism and are commonly seen in chronic liver disease, particularly cirrhosis.</p>
                    
                    <h4>Palmar Erythema</h4>
                    <p><strong>Reddening of the palms</strong>, particularly over the hypothenar and thenar eminences. Palmar erythema is also linked to increased estrogen levels and is commonly seen in chronic liver disease.</p>
                    
                    <h4>Xanthomas</h4>
                    <p><strong>Yellowish deposits of cholesterol</strong> in the skin, often seen around the eyes (<strong>xanthelasma</strong>), on the elbows, knees, or buttocks. Xanthomas occur due to impaired lipid metabolism in liver disease, leading to elevated cholesterol levels.</p>
                    
                    <h4>Portal Hypertension</h4>
                    <p><strong>Increased pressure in the portal vein</strong>, leading to complications such as ascites, variceal hemorrhage, and splenomegaly. Portal hypertension is a common consequence of cirrhosis and other chronic liver conditions.</p>
                    
                    <h4>Ascites</h4>
                    <p><strong>Accumulation of fluid</strong> in the abdominal cavity, leading to abdominal swelling and discomfort. Ascites is often a result of portal hypertension and reduced albumin production by the liver.</p>
                    
                    <h4>Variceal Hemorrhage</h4>
                    <p><strong>Life-threatening bleeding</strong> from dilated veins (varices) in the esophagus or stomach, which develop due to increased pressure from portal hypertension. Variceal hemorrhage is a serious complication of advanced liver disease.</p>
                    
                    <h4>Encephalopathy</h4>
                    <p>A spectrum of <strong>neuropsychiatric abnormalities</strong> ranging from mild confusion to coma. Hepatic encephalopathy occurs due to the accumulation of toxins (e.g., ammonia) that the liver normally detoxifies, leading to impaired brain function.</p>
                    
    
                </div>
              </section>
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Classification of Liver Disease in Children</a>
          </h2>
        </header>
        <div class='body'>

            <h4>Neonatal</h4>
            <h4>Neonatal Cholestatic Disorders</h4>
            
            <h4>A. Intrahepatic</h4>
            <ul>
                <li><strong>Infections</strong> - intrauterine, perinatal</li>
                <li><strong>Genetic/Metabolic</strong>:
                    <ul>
                        <li>Alagille syndrome</li>
                        <li>Œ±1-antitrypsin deficiency (7%)</li>
                        <li>Inborn errors of metabolism:
                            <ul>
                                <li>Galactosemia</li>
                                <li>Tyrosinemia</li>
                                <li>Cystic fibrosis</li>
                                <li>Progressive familial intrahepatic cholestasis</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li><strong>Endocrine</strong> - Hypothyroidism, hypopituitarism</li>
                <li><strong>Chromosomal</strong> - Trisomies</li>
                <li><strong>Toxins</strong> - TPN-associated cholestasis</li>
                <li><strong>Idiopathic Neonatal Hepatitis</strong> (35%)</li>
            </ul>
            
            <h4>B. Extrahepatic</h4>
            <ul>
                <li><strong>Biliary atresia</strong> (30%)</li>
                <li>Choledochal cyst</li>
                <li>Spontaneous perforation of the bile duct</li>
                <li>Stenosis of the common bile duct</li>
                <li>Cholelithiasis</li>
            </ul>
            
            <h4>Late Infancy and Childhood</h4>
            <ul>
                <li><strong>Hepatitis</strong> ‚Äì acute & chronic</li>
                <li>Complications of liver disease</li>
                <li>Hepatic failure</li>
                <li>Cirrhosis</li>
                <li>Portal hypertension</li>
                <li>Hepatic tumors</li>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Laboratory Investigation for Liver Disorders</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Liver Function Tests</strong>:
                    <ul>
                        <li><strong>Serum transaminase</strong>: ALT (alanine transferase) ‚Üë, AST (aspartate transferase) ‚Üë, ALP (alkaline phosphatase) ‚Üë</li>
                        <li><strong>Serum protein</strong>: Albumin ‚Üì, in chronic hepatitis, <strong>Ig</strong> ‚Üë</li>
                        <li><strong>Bilirubin</strong>:
                            <ul>
                                <li><strong>Urobilinogen</strong> ‚Üë in early stages (due to interrupted enterohepatic circulation)</li>
                                <li>In <strong>autoimmune hepatitis (AIH)</strong>, both direct and indirect bilirubin ‚Üë</li>
                            </ul>
                        </li>
                        <li><strong>Prothrombin time</strong> may be prolonged, especially in fulminant hepatitis</li>
                        <li><strong>Blood ammonia</strong></li>
                    </ul>
                </li>
                <li><strong>Ultrasound examination</strong></li>
                <li><strong>Liver biopsy</strong></li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Hepatitis</a>
          </h2>
        </header>
        <div class='body'>
            
            <section id='heading-4-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1'>Introduction</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Hepatitis</strong>: Inflammation of the liver.
                            <ul>
                                <li><strong>Tender hepatomegaly</strong></li>
                                <li>Fever, nausea, vomiting, jaundice, dark urine, fatigue, joint pain</li>
                            </ul>
                        </li>
                        <li><strong>50% of children</strong> do not develop jaundice.</li>
                        <li><strong>Large tender liver</strong> is common.</li>
                        <li><strong>30%</strong> will have <strong>spleenomegaly</strong></li>
                        <li><strong>Coagulation</strong> is usually normal.
                            <ul>
                                <li>Liver function derangement such as high ALT/AST</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <h4>Viral Hepatitis</h4>
                    <ul>
                        <li><strong>Types</strong>:
                            <ul>
                                <li><strong>Acute hepatitis</strong></li>
                                <li><strong>Chronic hepatitis</strong>:
                                    <ul>
                                        <li><strong>Chronic Persistent Hepatitis</strong> ‚Äì asymptomatic</li>
                                        <li><strong>Chronic Active Hepatitis</strong> ‚Üí Cirrhosis of the liver ‚Üí HCC</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                    </ul>
                    
    
                </div>
              </section>

              <section id='heading-4-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-2'>Aetiology</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Hepatotropic viruses</strong> (A to G) are responsible for 90-99% of viral hepatitis.</li>
                        <li><strong>McCallum</strong> in 1947 labeled the two known hepatitis viruses A and B.</li>
                        <li>Other viral agents include:
                            <ul>
                                <li>Yellow Fever</li>
                                <li>Lassa</li>
                                <li>Ebola</li>
                                <li>Herpes</li>
                                <li>Marburg</li>
                                <li>Epstein-Barr</li>
                                <li>Cytomegalovirus</li>
                            </ul>
                        </li>
                        <li><strong>Seronegative hepatitis</strong></li>
                    </ul>
                    
                    <h4>Causes of Acute Hepatitis/ALF</h4>
                    <ul>
                        <li><strong>Infection</strong>:
                            <ul>
                                <li><strong>Viral</strong>:
                                    <ul>
                                        <li>Hepatitis A, B, C, D, E</li>
                                        <li>Epstein-Barr virus</li>
                                        <li>Cytomegalovirus</li>
                                        <li>Yellow fever</li>
                                    </ul>
                                </li>
                                <li><strong>Bacteria</strong>:
                                    <ul>
                                        <li>Leptospirosis</li>
                                    </ul>
                                </li>
                                <li><strong>Parasite</strong>:
                                    <ul>
                                        <li>Toxoplasma gondii</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li><strong>Toxins</strong>:
                            <ul>
                                <li>Alcohol</li>
                                <li>Drugs: PCM, Isoniazid, Halothane</li>
                                <li>Amanita phalloides (poisonous mushroom)</li>
                            </ul>
                        </li>
                        <li><strong>Wilson‚Äôs disease</strong></li>
                        <li><strong>Autoimmune disease</strong></li>
                        <li><strong>Reye‚Äôs syndrome</strong></li>
                    </ul>
                    
    
                                <!-- image here -->
            <div class="image-container">
                <img src="../figures/hepatic-disorders-in-children (1).gif" alt="" onclick="openModal(this)">
                <div class="caption">Causes of hepatitis</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Causes of hepatitis</div>
              </div>



              <table class="note-table">
                <thead>
                  <tr>
                    <th colspan="3">Various Causes of ALF</th>
                  </tr>
                  <tr>
                    <th>Cause</th>
                    <th>Examples</th>
                    <th>Comment</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td>Drugs and Toxins</td>
                    <td>
                      <ul>
                        <li>Acetaminophen</li>
                        <li>Amanita phalloides</li>
                        <li>Isoniazid</li>
                        <li>Halothane</li>
                      </ul>
                    </td>
                    <td>Acetaminophen poisoning is the overall leading cause of ALF in the US</td>
                  </tr>
                  <tr>
                    <td>Viral Infection</td>
                    <td>
                      <ul>
                        <li>Hepatitis A</li>
                        <li>Hepatitis B (+/-D)</li>
                        <li>Hepatitis E</li>
                        <li>Herpes simplex virus</li>
                      </ul>
                    </td>
                    <td>Hepatitis C is a very rare cause of ALF</td>
                  </tr>
                  <tr>
                    <td>Vascular problems</td>
                    <td>
                      <ul>
                        <li>Shock</li>
                        <li>Heat stroke</li>
                        <li>Tumor infiltrating the liver</li>
                      </ul>
                    </td>
                    <td>Most often seen after cardiac arrest, major blood loss, or iatrogenic ligation of the major blood vessels feeding the liver</td>
                  </tr>
                  <tr>
                    <td>Metabolic/Miscellaneous</td>
                    <td>
                      <ul>
                        <li>Wilson Disease</li>
                        <li>Acute fatty liver of pregnancy</li>
                        <li>Alpha-1 antitrypsin deficiency</li>
                        <li>Autoimmune hepatitis</li>
                      </ul>
                    </td>
                    <td>Family screening is appropriate for many metabolic/genetic causes of ALF</td>
                  </tr>
                  <tr>
                    <td>Indeterminate</td>
                    <td>Unknown</td>
                    <td>Approximately 15%-20% of adult ALF cases, and up to 50% of ALF in children, cannot be attributed to a specific cause.</td>
                  </tr>
                </tbody>
              </table>
              



                </div>
              </section>

              <section id='heading-4-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-3'>Signs & Symptoms</a>
                  </h3>
                </header>
                <div class='body'>
                    <p>Some persons, particularly young children, are asymptomatic. When symptoms are present, they usually occur abruptly and can include the following:</p>
                    <ul>
                        <li><strong>Fever</strong></li>
                        <li><strong>Fatigue</strong></li>
                        <li><strong>Loss of appetite</strong></li>
                        <li><strong>Nausea</strong></li>
                        <li><strong>Vomiting</strong></li>
                        <li><strong>Abdominal pain</strong></li>
                        <li><strong>Dark urine</strong></li>
                        <li><strong>Clay-colored bowel movements</strong></li>
                        <li><strong>Joint pain</strong></li>
                        <li><strong>Jaundice</strong></li>
                    </ul>
                    
    
                </div>
              </section>

              <section id='heading-4-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-4'>Pathophysiology</a>
                  </h3>
                </header>
                <div class='body'>

                    <h4>Pre-Icteric Period</h4>
                    <ul>
                        <li>In <strong>Hepatitis A (HA)</strong> and <strong>Hepatitis E (HE)</strong>, the onset is abrupt with fever; but in <strong>Hepatitis B (HB)</strong> and <strong>Hepatitis C (HC)</strong>, the onset is insidious.</li>
                        <li>The initial symptoms include: loss of appetite, nausea, vomiting, lassitude, abdominal pain, and diarrhea.</li>
                        <li>By the end of this period, the urine darkens. In a few patients, especially children, fever, headache, and upper respiratory tract symptoms are the main manifestations.</li>
                        <li>The duration of this period varies from 1 to 21 days, with an average of 5-7 days.</li>
                    </ul>
                    
                    <h4>Icteric Period</h4>
                    <ul>
                        <li>The urine deepens continuously, and jaundice appears on the skin and sclera within 2 weeks.</li>
                        <li><strong>Subjective symptoms</strong> abate.</li>
                        <li><strong>Pruritus</strong> may appear about 1 week into this period.</li>
                        <li>The liver is palpable in 7% of cases, and the spleen is palpable in 20% of cases.</li>
                        <li>The period lasts 2-6 weeks.</li>
                    </ul>
                    
                    <h4>Convalescent Period</h4>
                    <ul>
                        <li>The jaundice disappears gradually, and symptoms abate or disappear.</li>
                        <li>The liver and spleen retract, and liver function returns to normal.</li>
                        <li>The period lasts 2 weeks to 4 months, with an average of 1 month.</li>
                        <li>About 10% of Hepatitis B (HB) and 50% of Hepatitis C (HC) cases will become chronic hepatitis.</li>
                        <li><strong>Acute Hepatitis D:</strong>
                            <ul>
                                <li>Co-infection with HBV</li>
                                <li>Super-infection with HBV</li>
                            </ul>
                        </li>
                        <li><strong>Acute Hepatitis E</strong> is similar to acute hepatitis A, but cholestasis is more obvious, and symptoms and signs are more severe.</li>
                        <li>If women with pregnancy suffer from HE, it may lead to <strong>fulminant hepatitis</strong>.</li>
                        <li>If HBV super-infects HEV or HCV, it may lead to <strong>fulminant hepatitis</strong>.</li>
                    </ul>
                    
                </div>
              </section>

              <section id='heading-4-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-4'>Viral Hepatitis Classification</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Viral hepatitis</strong> is classified based on the duration of the disease. This may be acute or chronic.</li>
                        <li><strong>Acute viral hepatitis</strong> - less than 6 months.</li>
                        <li><strong>Anicteric hepatitis</strong></li>
                        <li><strong>Chronic viral hepatitis</strong> - more than six months:
                            <ul>
                                <li>Chronic active</li>
                                <li>Chronic persistent</li>
                                <li>Chronic lobular</li>
                            </ul>
                        </li>
                        <li>Current classification of chronic hepatitis uses the <strong>Knodell score</strong> (aetiology, necroinflammation (stage), and fibrosis (histological grade)).</li>
                    </ul>
                    
                    <br>

                    <table class="note-table">
                      <thead>
                        <tr>
                            <th colspan="2">Viral Hepatitis</th>
                        </tr>
                        <tr>
                          <th>Type of Hepatitis</th>
                          <th>Mode of Transmission</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td>Hepatitis A</td>
                          <td>
                            <ul>
                              <li>Contaminated food and water.</li>
                            </ul>
                          </td>
                        </tr>
                        <tr>
                          <td>Hepatitis B</td>
                          <td>
                            <ul>
                              <li>Sexual intercourse.</li>
                              <li>Sharing infected needles.</li>
                            </ul>
                          </td>
                        </tr>
                        <tr>
                          <td>Hepatitis C</td>
                          <td>
                            <ul>
                              <li>Sexual intercourse.</li>
                              <li>Sharing infected needles.</li>
                            </ul>
                          </td>
                        </tr>
                        <tr>
                          <td>Hepatitis D</td>
                          <td>
                            <ul>
                              <li>Must have hepatitis B.</li>
                              <li>Found mainly in intravenous drug users.</li>
                            </ul>
                          </td>
                        </tr>
                        <tr>
                          <td>Hepatitis E</td>
                          <td>
                            <ul>
                              <li>Contaminated water from poor sanitation.</li>
                            </ul>
                          </td>
                        </tr>
                      </tbody>
                    </table>
                    
    
                    <br>


                    <table class="note-table">
                      <thead>
                            <tr>
                                <th colspan="6">Type of Hepatitis</th>
                            </tr>
                        <tr>
                          <th></th>
                          <th>A</th>
                          <th>B</th>
                          <th>C</th>
                          <th>D</th>
                          <th>E</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <th>Source of virus</th>
                          <td>feces</td>
                          <td>blood/ blood-derived body fluids</td>
                          <td>blood/ blood-derived body fluids</td>
                          <td>blood/ blood-derived body fluids</td>
                          <td>feces</td>
                        </tr>
                        <tr>
                          <th>Route of transmission</th>
                          <td>fecal-oral</td>
                          <td>percutaneous permucosal</td>
                          <td>percutaneous permucosal</td>
                          <td>percutaneous permucosal</td>
                          <td>fecal-oral</td>
                        </tr>
                        <tr>
                          <th>Chronic infection</th>
                          <td>no</td>
                          <td>yes</td>
                          <td>yes</td>
                          <td>yes</td>
                          <td>no</td>
                        </tr>
                        <tr>
                          <th>Prevention</th>
                          <td>pre/post-exposure immunization</td>
                          <td>pre/post-exposure immunization</td>
                          <td>blood donor screening; risk behavior modification</td>
                          <td>pre/post-exposure immunization; risk behavior modification</td>
                          <td>ensure safe drinking water</td>
                        </tr>
                      </tbody>
                    </table>
                    
                    <br>


                    <table class="note-table">
                      <thead>
                        <tr>
                          <th>CHARACTERISTIC</th>
                          <th>HEPATITIS A</th>
                          <th>HEPATITIS B</th>
                          <th>HEPATITIS C</th>
                          <th>HEPATITIS D</th>
                          <th>HEPATITIS E</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td>Transmission</td>
                          <td>Fecal-oral (ingestion of contaminated food and water)</td>
                          <td>Parenteral (injection of contaminated blood or other body fluids)</td>
                          <td>Parenteral</td>
                          <td>Parenteral (host must be coinfected with hepatitis B)</td>
                          <td>Fecal-oral</td>
                        </tr>
                        <tr>
                          <td>Agent</td>
                          <td>Hepatitis A virus (HAV); single-stranded RNA; no envelope</td>
                          <td>Hepatitis B virus (HBV); double-stranded DNA; envelope</td>
                          <td>Hepatitis C virus (HCV); single-stranded RNA; envelope</td>
                          <td>Hepatitis D virus (HDV); single-stranded RNA; envelope from HBV</td>
                          <td>Hepatitis E virus (HEV); single-stranded RNA; no envelope</td>
                        </tr>
                        <tr>
                          <td>Incubation period</td>
                          <td>2 to 6 weeks</td>
                          <td>4 to 26 weeks</td>
                          <td>2 to 22 weeks</td>
                          <td>Uncertain</td>
                          <td>2 to 6 weeks</td>
                        </tr>
                        <tr>
                          <td>Manifestations or symptoms</td>
                          <td>Mostly subclinical; severe cases: fever, headache, malaise, jaundice</td>
                          <td>Frequently subclinical; similar to HAV, but fever, headache absent, and more likely to progress to severe liver damage</td>
                          <td>Similar to HBV</td>
                          <td>Severe liver damage; high mortality rate</td>
                          <td>Similar to HAV, but pregnant women may have high mortality rate</td>
                        </tr>
                        <tr>
                          <td>Chronic liver disease</td>
                          <td>No</td>
                          <td>Yes</td>
                          <td>Yes</td>
                          <td>Yes</td>
                          <td>No</td>
                        </tr>
                        <tr>
                          <td>Vaccines</td>
                          <td>Available soon, but immunoglobulins give temporary protection</td>
                          <td>Genetically engineered</td>
                          <td>None</td>
                          <td>HBV vaccine is protective because coinfection required</td>
                          <td>None</td>
                        </tr>
                      </tbody>
                    </table>
                    
                    <br>

                    <section id='heading-4-4-1'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-4-4-1'>Hepatitis A Virus</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li><strong>HAV antigen</strong> was first identified in feces in 1973.</li>
                                <li>It is a <strong>picornavirus</strong> with a diameter of 27 nm.</li>
                                <li>The incubation period is <strong>15-50 days</strong>.</li>
                                <li>In endemic areas, infection is acquired early in life largely due to its <strong>fecal-oral</strong> mode of transmission.</li>
                                <li><strong>Oro-anal sex</strong> can also be a mode of transmission.</li>
                                <li>Infection is usually <strong>asymptomatic</strong>, with clinical infection recognized in only 5% of cases.</li>
                                <li>It is a <strong>self-limiting infection</strong>.</li>
                                <li>The virus is not directly cytopathic; liver damage is due to <strong>immune-mediated cytotoxicity</strong>.</li>
                                <li>Over <strong>80%</strong> of pre-school children in endemic areas have protective antibodies.</li>
                                <li>There is <strong>no chronic carrier state</strong>.</li>
                                <li>An effective <strong>vaccine</strong> is available.</li>
                                <li>It is the <strong>most common viral hepatitis</strong>.</li>
                                <li><strong>Clinical presentations</strong>:
                                    <ul>
                                        <li>Asymptomatic</li>
                                        <li>Mild illness, recovering within 2-4 weeks (Majority)</li>
                                        <li>Prolonged cholestatic hepatitis (self-limiting)</li>
                                        <li>Acute fulminant hepatitis</li>
                                        <li>No chronic liver disease</li>
                                    </ul>
                                </li>
                                <li><strong>Diagnosis:</strong> Confirmed by <strong>IgM HAV antibody</strong>.</li>
                                <li><strong>Treatment:</strong> No special treatment; rest.</li>
                                <li><strong>Prevention in contacts/travelers:</strong>
                                    <ul>
                                        <li><strong>Vaccination</strong> (Active immunization)</li>
                                        <li><strong>Immunoglobulin</strong></li>
                                    </ul>
                                </li>
                            </ul>
                            
                
                        </div>
                      </section>

                      <section id='heading-4-4-2'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-4-4-2'>Hepatitis B Virus</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>This is the most studied of the hepatotropic viruses because its diagnosis has been made easy by the historic discovery of the <strong>Australian antigen</strong>, now called <strong>HBsAg</strong>.</li>
                                <li><strong>Hepatitis B Virus (HBV)</strong> has a global distribution with about <strong>300 million carriers</strong>.</li>
                                <li>HBV causes about <strong>2 million deaths annually</strong>, with <strong>500,000</strong> from fulminant hepatitis.</li>
                                <li>About <strong>2 billion people</strong> have markers of the disease worldwide.</li>
                                <li>The most effective means of transmission is through <strong>blood and blood products</strong>.</li>
                                <li><strong>Routes of transmission</strong>:
                                    <ul>
                                        <li><strong>Humoral transmission</strong> (parenteral transmission)</li>
                                        <li><strong>Mother to infant transmission</strong> (vertical transmission)</li>
                                        <li><strong>Sexual contact transmission</strong></li>
                                        <li><strong>Insect transmission</strong></li>
                                    </ul>
                                </li>
                                <li><strong>Clinical presentations</strong>:
                                    <ul>
                                        <li>Asymptomatic</li>
                                        <li>Mild illness, recovering within 2-4 weeks (Majority)</li>
                                        <li>Acute hepatitis -> Resolution/Acute fulminant hepatic failure (1-2%)</li>
                                        <li>Chronic carriers (5-10%)</li>
                                    </ul>
                                </li>
                            </ul>
                            

                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/hepatic-disorders-in-children (1).png" alt="" onclick="openModal(this)">
                <div class="caption">HBV disease progression</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">HBV disease progression</div>
              </div>
                
              <h4>Serological Diagnosis of HBV</h4>
              <ul>
                  <li>A battery of <strong>serological tests</strong> is used for the diagnosis of acute and chronic hepatitis B infection.</li>
                  <li><strong>HBsAg</strong> - used as a general marker of infection.</li>
                  <li><strong>HBsAb</strong> - used to document recovery and/or immunity to HBV infection.</li>
                  <li><strong>Anti-HBc IgM</strong> - marker of acute infection.</li>
                  <li><strong>Anti-HBc IgG</strong> - indicates past or chronic infection.</li>
                  <li><strong>HBeAg</strong> - indicates active replication of the virus and therefore infectiveness.</li>
                  <li><strong>Anti-HBe</strong> - indicates that the virus is no longer replicating. However, the patient can still be positive for <strong>HBsAg</strong>, which is produced by integrated HBV.</li>
              </ul>
              

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hepatic-disorders-in-children (2).png" alt="" onclick="openModal(this)">
                <div class="caption">Possible Outcomes of HBV Infection`</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Possible Outcomes of HBV Infection`</div>
              </div>
              

              <h4>Prevention</h4>
              <ul>
                  <li><strong>Vaccination</strong>
                      <ul>
                          <li>Highly effective recombinant vaccines are now available.</li>
                          <li>Recommended for <strong>health care workers</strong>, <strong>EPI (Expanded Program on Immunization)</strong>, and <strong>neonates of HBsAg-positive mothers</strong>.</li>
                      </ul>
                  </li>
                  <li><strong>Hepatitis B Immunoglobulin (HBIG)</strong>
                      <ul>
                          <li>HBIG may be used to protect persons who are exposed to hepatitis B.</li>
                          <li>It is particularly efficacious within <strong>48 hours</strong> of the incident.</li>
                          <li>May also be given to neonates at increased risk of contracting hepatitis B, such as those whose mothers are <strong>HBsAg</strong> and <strong>HBeAg</strong> positive.</li>
                      </ul>
                  </li>
                  <li><strong>Other Measures</strong>
                      <ul>
                          <li>Screening of blood donors.</li>
                          <li>Blood and body fluid precautions.</li>
                      </ul>
                  </li>
              </ul>
              
              <h4>Chronic HBV Carriers</h4>
              <ul>
                  <li>These are individuals who harbor the virus for <strong>>6 months</strong> without any evidence of liver disease.</li>
                  <li>They should be monitored closely with serial <strong>liver function tests</strong>, <strong>alpha-fetoprotein</strong>, and <strong>liver ultrasonography</strong>.</li>
              </ul>
              
                        </div>
                      </section>

                      <section id='heading-4-4-3'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-4-4-3'>Hepatitis C Virus</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>Previously known as <strong>parenteral NonA-NonB hepatitis virus</strong>.</li>
                                <li>It is the leading cause of chronic liver disease worldwide.</li>
                                <li>About <strong>3%</strong> of the world population is chronically infected.</li>
                                <li>Chronic infection is a major cause of <strong>cirrhosis</strong> and <strong>hepatocellular carcinoma (HCC)</strong> in the developed world.</li>
                                <li>Most infections (<strong>85%</strong>) lead to chronicity.</li>
                                <li>Transmission is most effective through serum.</li>
                                <li>Sexual transmission is rare because of the usually low level of viraemia.</li>
                                <li>Vertical transmission is possible with marked viraemia.</li>
                                <li><strong>Transmission:</strong>
                                    <ul>
                                        <li>Blood transfusion (e.g., <strong>Haemoglobinopathies</strong>, <strong>Haemophilia</strong>).</li>
                                        <li>Blood transfusion is now rare due to improved screening.</li>
                                    </ul>
                                </li>
                                <li><strong>Clinical Presentation:</strong>
                                    <ul>
                                        <li><strong>Acute infection</strong> is mild.</li>
                                        <li><strong>50%</strong> develop chronic liver disease, which may later progress to <strong>cirrhosis</strong> or <strong>HCC</strong>.</li>
                                    </ul>
                                </li>
                            </ul>
                            
                
                        </div>
                      </section>

                      <section id='heading-4-4-4'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-4-4-4'>Hepatitis D Virus</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>Exclusively found in patients with <strong>HBsAg</strong>.</li>
                                <li>Requires <strong>HBV</strong> for its replication.</li>
                                <li>Occurs in <strong>coinfection</strong> or <strong>superinfection</strong> states.</li>
                                <li><strong>Superinfection</strong> has a worse prognosis.</li>
                                <li>Common in <strong>drug addicts</strong>, <strong>haemophiliacs</strong>, and institutional patients.</li>
                                <li><strong>IgM/IgG anti-HDV</strong> and <strong>HDV-RNA</strong> are used for diagnosis.</li>
                                <li><strong>Vaccination</strong> for HBV prevents HDV infection.</li>
                                <li>HBV treatment also treats HDV infection.</li>
                            </ul>
                            
                
                        </div>
                      </section>

                      <section id='heading-4-4-5'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-4-4-5'>Hepatitis E Virus</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li><strong>HEV</strong> is a common cause of epidemic acute hepatitis in various parts of Southeast and Southern Asia, Burma, and West Africa.</li>
                                <li>In 1957, it was the cause of an outbreak of acute hepatitis in New Delhi.</li>
                                <li>About 2% of blood donors are seropositive in some Western countries.</li>
                                <li><strong>HEV</strong> is a 27-34nm single-stranded RNA virus.</li>
                                <li>Transmitted like <strong>HAV</strong> as well as vertically.</li>
                                <li>Incubation period is about 2-9 weeks.</li>
                            </ul>
                            
                
                        </div>
                      </section>
                </div>
              </section>

              <section id='heading-4-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-5'>Diagnosis, Treatment, Prevention</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4>Detection of the Markers of Hepatitis Virus</h4>
                    <ul>
                        <li><strong>Serologic Marker of A</strong>
                            <ul>
                                <li><strong>Anti-HAV IgM</strong>: Recent infection</li>
                                <li><strong>Anti-HAV IgG</strong>: Past infection</li>
                            </ul>
                        </li>
                        <li><strong>Sero-immunologic Marker of B</strong>
                            <ul>
                                <li><strong>HBsAg</strong> - Anti-HBs</li>
                                <li><strong>HBcAg</strong> - Anti-HBc</li>
                                <li><strong>HBeAg</strong> - Anti-Hbe</li>
                            </ul>
                        </li>
                        <li><strong>Serological Marker of C</strong>
                            <ul>
                                <li><strong>Anti-HCV IgM</strong></li>
                                <li><strong>Anti-HCV IgG</strong></li>
                            </ul>
                        </li>
                    </ul>
                    
                                <!-- image here -->
            <div class="image-container">
                <img src="../figures/hepatic-disorders-in-children (3).png" alt="" onclick="openModal(this)">
                <div class="caption">Diagnosis of hepatitis</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Diagnosis of hepatitis</div>
              </div>
    

              <h4>Treatment</h4>
              <ul>
                  <li>Isolation</li>
                  <li>Rest</li>
                  <li>Diet</li>
                  <li>Anti-virus therapy (Lamivudine, Interferons)</li>
              </ul>
              
              <h4>Prevention</h4>
              <ul>
                  <li>Control of source of infection</li>
                  <li>Cut off the route of transmission</li>
                  <li>Protection of susceptible population
                      <ul>
                          <li>Active immunity</li>
                          <li>Passive immunity</li>
                      </ul>
                  </li>
                  <li>Treatment of uncomplicated acute viral hepatitis is supportive: 
                      <ul>
                          <li>Bed rest, avoidance of alcohol, and normal diet</li>
                      </ul>
                  </li>
                  <li>Fulminant hepatitis is treated with anti-liver failure regimen.</li>
                  <li>Chronic HBV and HCV require both supportive and antiviral therapy.</li>
              </ul>
              
                </div>
              </section>
        </div>
      </section>








      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
